 |
|
Effect of Morphine on Growth of Metastatic Colon Cancer In Vivo
Mark P. Yeager, MD;
Thomas A. Colacchio, MD
Arch Surg. 1991;126(4):454-456.
Abstract
• Control of colon cancer depends, in part, on intact immune defense mechanisms. Since opiates are known to affect some components of immune function, this study was conducted to determine the effect of high-dose subcutaneous morphine sulfate and of low-dose intrathecal morphine on the postoperative growth of metastatic colon cancer. Five groups of 15 Fischer 344 rats were given intraportal injections of colon cancer cells as follows: group 1, control; group 2, daily subcutaneous injections of 20-mg/kg morphine the day before and for 2 days after colon cancer cell inoculation; group 3, daily subcutaneous injections of saline; group 4, daily intrathecal injections of 20 µg of morphine; and group 5, daily intrathecal injections of saline. There was a significant decrease in the hepatic tumor burden in group 2 compared with groups 1 and 3 and a significant increase in the hepatic tumor burden in groups 4 and 5 compared with group 1. This study demonstrates that intermittent injections of a narcotic may decrease the growth of tumor cells that gain access to the circulation during a surgical procedure. In addition, the results support the concept that tumor cells entering the circulation during a vulnerable period of postoperative immunosuppression are more likely to survive as metastatic tumor.
(Arch Surg. 1991;126:454-456)
Author Affiliations
From the Departments of Anesthesiology and Medicine (Dr Yeager) and Surgery (Dr Colacchio), Dartmouth-Hitchcock Medical Center, Hanover, NH.
Footnotes
Accepted for publication January 12, 1991.
Read before the 43rd Annual Cancer Symposium of the Society of Surgical Oncology, Washington, DC, May 20, 1990.
Reprint requests to Department of Anesthesiology, Dartmouth-Hitchcock Medical Center, 2 Maynard St, Hanover, NH 03756 (Dr Yearger).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Risks and benefits of thoracic epidural anaesthesia
Freise and Van Aken
Br J Anaesth 2011;107:859-868.
ABSTRACT
| FULL TEXT
Opioids and the immune system
Sacerdote
Palliat Med 2006;20:9-15.
ABSTRACT
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Tegeder and Geisslinger
Pharmacol. Rev. 2004;56:351-369.
ABSTRACT
| FULL TEXT
G Protein-independent G1 Cell Cycle Block and Apoptosis with Morphine in Adenocarcinoma Cells: Involvement of p53 Phosphorylation
Tegeder et al.
Cancer Res. 2003;63:1846-1852.
ABSTRACT
| FULL TEXT
The Effects of Tramadol and Morphine on Immune Responses and Pain After Surgery in Cancer Patients
Sacerdote et al.
Anesth. Analg. 2000;90:1411-1414.
ABSTRACT
| FULL TEXT
Clinical research on heroin in cancer pain control
Baumrucker
AM J HOSP PALLIAT CARE 2000;17:8-9.
|
